- Home
- Business & Services 2023788-19-2Tirzepatide 9107463-68-2Semaglutide 2381089-8-32 121062-08-6
2023788-19-2Tirzepatide 9107463-68-2Semaglutide 2381089-8-32 121062-08-6
Ernakulam, Baláže
12th Mar, 2025
Views: 3
Description:
Tirzepatide is a novel drug developed by Eli Lilly and Company, primarily targeting the GIP (glucose dependent insulinotropic polypeptide) receptor and GLP
Contact Information
Location
9796, Baláže, Ernakulam
Phone
97961694
Email
liq134763@gmail.com
₹
9
More Listing
17.jpg)
10.jpg)



